FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
Powered by Google


Purpose / Learning Objectives

Speaker Biographies

Video Presentation

Presentation Transcript

Download Slides

Optional Online Quiz

Generics Homepage

Generics Consumer Information

Orange Book

Online Training Seminar

"The FDA Process for Approving Generic Drugs"

June 2007

(No Credit Is Offered)


This seminar provides viewers with an overview of the Food and Drug Administration's role in the generic drug process. It discusses various aspects of the Abbreviated New Drug Application (ANDA) process, including how FDA's approval assures that generic drugs are safe, effective, and high quality drug products.


  1. Cite legislation that enables the approval of generic drug products;
  2. Describe the differences between the generic drug approval process and the innovator drug approval process;
  3. Identify information contained in the "Orange Book";
  4. Describe the methodology for determination of bioequivalence of drug products;
  5. Describe the complexities of the patent certification process and the impact on the approval of generic drug products.

 Advance to Next Section....


to top arrow Back to Top     back arrow Back to CDERLearn

PDF document PDF requires the free Adobe Acrobat Reader

Date created: July 9, 2007

horizonal rule